AzTrials
AzTrials

Periapical PeriodontitisNCT01799187

Research of Revascularization in Immature Teeth With Periapical Periodontitis

A study testing revascularization and apexification in people with Periapical Periodontitis, run by Junqi Ling at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Revascularization is an alternative new treatment of immature permanent teeth with necrotic pulp nowadays while apexification is the traditional therapy. The investigators suppose that revascularization is superior to apexification at developing the root of immature permanent teeth and reducing the risk of root… Read more about this study

Who is it for?
Ages 6 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Periapical Periodontitis
What is being tested?
revascularization and apexification
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
190 participants
Where
1 siteChina
Study dates
Jul 2012to Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • clinical diagnosis of periapical periodontitis
  • must be immature permanent teeth
  • must be local Guangzhou

Who cannot join

  • blood disease
  • residual root that is advised to extract
  • serious periodontitis
  • women in pregnancy

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Guanghua hospital of stomotology,Sun Yat-sen University

    Guangzhou, Guangdong, 510055

    ling j q, PhD, 020-83863002, lingjq@mail.sysu.edu.cn

    Recruiting

Other trials in China

About this study

Official title: Randomized Controlled Research of Revascularization in Immature Permanent Teeth With Periapical Periodontitis

Revascularization is an alternative new treatment of immature permanent teeth with necrotic pulp nowadays while apexification is the traditional therapy. The investigators suppose that revascularization is superior to apexification at developing the root of immature permanent teeth and reducing the risk of root fracture,and the research is designed.

Read the detailed description

The investigators design to collect a group of patients presenting immature permanent teeth with periapical periodontitis in certain criterion. The investigators will divide the patients into two groups randomly. One group will get treated with revascularization while the other with apexification. The investigators want to evaluate the short-term and long-term effects of the two groups to get a conclusion of the clinical value of revascularization.

Being tested
revascularization, apexification
Keywords
Immature Permanent Teeth
Medical subject headings
Periapical Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • revascularizationProcedure or surgery

    revascularization include 3 steps: root disinfected,induction of bleeding and revascularization include 3 steps: root disinfected,induction of bleeding and sealing

  • apexificationProcedure or surgery

    apexification uses calcium hydroxide as root medication

Study groups in NCT01799187
Study groupRoleWhat they receive
revascularizationExperimentalrevascularization is is an alternative new treatment of immature permanent teeth with necrotic pulp. The use of triple antibiotic paste is followed by Induction of bleeding from the apical root during this intervention.
Receives: Procedure: revascularization
apexificationActive comparatorapexification is a traditional therapy of immature permanent teeth with necrotic pulp.calcium hydroxide is served as medication to induce the developing of root .
Receives: Procedure: apexification

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evidence of lesion healing confirmed by cone beam computed tomography

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2013 (estimated)
  2. Study startJul 2012
  3. Primary completionJul 2015 (estimated)
  4. Study completionJul 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
190 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01799187
Sponsor's protocol ID
5010YT
Other IDs
jqling
Status last verified
Jul 2014
First submitted
24 Feb 2013
Last updated
22 Jul 2014
Results posted
No
Data monitoring committee
Yes

Publications

  • Jung IY, Lee SJ, Hargreaves KM. Biologically based treatment of immature permanent teeth with pulpal necrosis: a case series. J Endod. 2008 Jul;34(7):876-87. doi: 10.1016/j.joen.2008.03.023. Epub 2008 May 16.

    PubMed 18571000

Questions about this trial

What is this clinical trial studying?

A study testing revascularization and apexification in people with Periapical Periodontitis, run by Junqi Ling at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Jul 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ling J Qi, PhD (020-83863002, lingjq@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evidence of lesion healing confirmed by cone beam computed tomography (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01799187, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in